Spherix Inc (SPEX.OQ)

SPEX.OQ on NASDAQ Stock Exchange Capital Market

5.31USD
1 Jul 2013
Price Change (% chg)

$0.92 (+20.96%)
Prev Close
$4.39
Open
$4.54
Day's High
$6.43
Day's Low
$4.54
Volume
25,476
Avg. Vol
1,852
52-wk High
$14.99
52-wk Low
$4.07

SPEX.OQ

Chart for SPEX.OQ

About

Spherix Incorporated (Spherix) is a scientific research company. The Company is enaged in developing biopharmaceutical products and providing technical and regulatory consulting services to food, consumer products and pharmaceutical companies. The Company operates in two segments: Biospherics Incorporated (Biospherics), the... (more)

Buy/Sell

No analyst recommendations are available for SPEX.OQ.
» Analyst Consensus

Overall

Beta: 0.03
Market Cap (Mil.): $3.65
Shares Outstanding (Mil.): 0.82
Dividend: --
Yield (%): --

Financials

  SPEX.OQ Industry Sector
P/E (TTM): -- 19.94 21.45
EPS (TTM): -10.81 -- --
ROI: -65.73 7.61 8.53
ROE: -124.15 10.77 12.87
Search Stocks

Competitors

  Price Change
Pfizer Inc. (PFE.N) $27.78 -0.23
Johnson & Johnson (JNJ.N) $86.63 +0.77
Bayer AG (BAYGn.DE) €82.37 +0.44
Bayer AG (BAYE.F) -- --
AstraZeneca plc (AZN.L) 3,151.00p +36.00
GlaxoSmithKline plc (GSK.L) 1,658.50p +10.50

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Thomson Reuters Stock Report - SPHERIX, INC. (SPEX-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Spherix Inc
Provider: S&P Capital IQ Quantitative Report
$58.00
Buy
SPHERIX INC (SPEX) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy
Spherix Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
ValuEngine Detailed Valuation Report for SPEX
Provider: ValuEngine, Inc.
$127.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks